2020 ASCO Virtual Direct™ Highlights
2020 ASCO Highlights on HER2+ MBC: Incorporating New HER2 Targeted Agents - Neratinib, Pertuzumab & T-DM-1
By
2020 ASCO Virtual Direct™ Highlights
FEATURING
Kevin Kalinsky
By
2020 ASCO Virtual Direct™ Highlights
FEATURING
Kevin Kalinsky
Comments 0
Login to view comments.
Click here to Login
